Glanzman Robert 4
4 · Clene Inc. · Filed Nov 4, 2021
Insider Transaction Report
Form 4
Clene Inc.CLNN
Glanzman Robert
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2021-11-04+100,000→ 100,000 totalExercise: $4.74Exp: 2031-11-04→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on November 4, 2021 as an option for 100,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested